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Abstract
Background: Respondents’ report of a previously diagnosed depression by a health professional is frequently used
to estimate depression prevalence. This study contributes to a better understanding of survey results based on this
measure by comparing it with a comprehensive standardized diagnostic interview.
Methods: Data came from the cross-sectional nationwide German Health Interview and Examination Survey for
Adults (DEGS1) and its mental health module (DEGS1-MH, n = 4483). In DEGS1, participants were asked whether
they have been diagnosed with depression by a physician or psychotherapist (last 12-month). DSM-IV-based
12-month major depressive disorder (MDD) and other mental disorders were assessed with the German version of
the Composite International Diagnostic Interview (CIDI). Time lag between both assessments was 6 weeks (median).
Results: 73.4% of participants reporting clinician-diagnosed depression met criteria for any mental disorder in the
CIDI (any affective disorder: 51.8%, any anxiety disorder: 54.7%). The proportion of participants reporting a clinician-
diagnosed depression who met MDD criteria was highest among those aged 18–29 years (62.6%) and decreased
with age (65–79 years: 29.8%). Among participants with MDD, the proportion with clinician-diagnosed depression
was 33.0%, highest among those aged 45–64 years (49.3%) and lowest among those aged 18–29 years (22.7%) and
30–44 years (20.3%). MDD severity was positively associated with clinician-diagnosed depression.
Conclusions: Respondents’ report of a clinician-diagnosed depression and major depression assessed with the CIDI
substantially differ. Concordance of both measures varies with age and severity of depressive symptoms. Health
surveys should assess a range of depression indicators in order to cover a wide spectrum.
Keywords: Depression, Diagnosis, Composite International Diagnostic Interview, General population, Health surveys
Background
In many large-scale health surveys, the prevalence of de-
pression is assessed by asking participants whether they
have been diagnosed with depression by a health profes-
sional in the past 12 months [1–4]. This simple measure
has various preconditions such as previous health care
utilization of the respondent, reporting depressive symp-
toms to a health professional, understanding the ques-
tion asked in the survey, and admitting the diagnosis in
the survey interview. In addition, the accuracy of this
measure in determining the existence of depression de-
pends on whether health professionals correctly diag-
nose their patient with depression. The latter can be at
least partly questioned considering the notable extent of
over- and under-diagnosis of depression in primary care
found in clinical and community studies [5–8].
Despite these preconditions, a recent general popula-
tion survey found that 12-month prevalence estimates
based on the respondent’s report of a clinician-diagnosis
of depression and an interviewer assessment of major
depression with a comprehensive standardized diagnos-
tic interview based on the Diagnostic and Statistical
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Manual of Mental Disorders-IV (DSM-IV) were on a
similar level [1]. Yet, the overlap of the two measures
was only moderate, and, in agreement with previous re-
search [2, 4, 9, 10], prevalence of major depression was
highest in younger age adults and of clinician-diagnosed
depression in middle-aged and older adults [1]. These
findings suggest that there are substantial differences be-
tween DSM-IV-based major depression and a clinician-
diagnosed depression and, as a consequence, that the
presence of major depression may not be inferred with
accuracy from the respondent’s report of a previous clin-
ician diagnosis. However, there is a lack of specific
knowledge about differences between both measures at
an individual level.
Considering the fact that depression is still quite often
assessed with a single question about clinician diagnoses
in health surveys, this study aims to contribute to a bet-
ter understanding of survey results based on the respon-
dent’s report of a clinician-diagnosed depression.
Therefore, we investigate the association between such
reports and independent diagnoses of depression in a
large general population survey. Specifically, we examine
the proportion of mental disorders based on a compre-
hensive standardized diagnostic research interview
among survey participants who report a clinician-
diagnosed depression as a function of sex, age, and de-
pression severity. Moreover, in order to examine the
false negative rate based on the question about a previ-
ous clinician diagnosis, we examine the proportion of
survey participants with major depression determined by
the diagnostic interview who do versus do not report
that a clinician diagnosed them with depression. Finally,
socio-demographic, health-related and mental health
characteristics are reported separately for survey partici-
pants with different combinations of depression diagno-
ses based on the cross-classification of diagnoses
according to a diagnostic interview administered in the
survey and the respondents’ reports of being diagnosed
by a clinician.
Methods
Study design and sample
Data come from the cross-sectional nationwide “German
Health Interview and Examination Survey for Adults”
(DEGS1) and its mental health module (DEGS1-MH; n
= 4483; age 18–79 years). The design, objectives and
methods have been described in detail elsewhere [11–
14]. Briefly, a random sample of persons aged 18–79
years stratified for sex, age and geographical location
was selected using two-stage clustered random sampling.
On the first stage, 180 sample points were drawn from
all German municipal communities, on the second stage,
participants were randomly drawn from population
registries of these sample points. For DEGS1-MH, all
DEGS1 participants with complete assessment (interview
and examinations) aged 18–79 years were eligible who
had consented to being re-contacted for the mental
health module, who had sufficient language skills and
who were available during the assessment period [11,
14]. In DEGS1, data were collected by self-administered
written questionnaire and a standardized physician-
administered computer-assisted personal interview
(CAPI) and physical and laboratory measurements. In
DEGS1-MH, 12-month and lifetime diagnoses of mental
disorders based on the diagnostic criteria of the DSM-
IV-TR were assessed in a CAPI using a modified version
of the Composite International Diagnostic Interview
(DIA-X/M-CIDI) [15, 16], a German version of the inter-
nationally established CIDI [15, 17, 18]. The median
time lag between DEGS1 and DEGS1-MH was 6 weeks
(inter quartile range 5–25 weeks). DEGS1 was approved
by the federal and state commissioners for data protec-
tion and by the ethics committee of Charité-Universi-
tätsmedizin Berlin (No.EA2/047/08). DEGS1-MH was
additionally approved by the ethics committee of the
Technische Universität Dresden (No.EK174062009). All
participants provided written informed consent.
Measures
Clinician-diagnosed depression based on the respondents’
report
Lifetime clinician-diagnosed depression was assessed in
the physician-administered CAPI in DEGS1, where par-
ticipants were asked: “Have you ever been diagnosed
with depression by a physician or a psychotherapist?” If
affirmed, 12-month clinician-diagnosed depression was
determined with the question: “Was the depression
present during the last 12 months?”
Major depressive disorder (MDD) and other mental
disorders based on a diagnostic interview
MDD in the past 12 months was determined by the
DIA-X/M-CIDI. In the DIA-X/M-CIDI, the presence of
depression symptoms is assessed in 30 single items,
which are grouped into the nine depression symptoms
of DSM-IV based on a standardized algorithm. MDD
was determined by applying all DSM-IV diagnostic cri-
teria. Compared to a clinical lifetime diagnosis, a sensi-
tivity of 0.95 (single depressive episode, lifetime) and
0.929 (recurrent major depressive episode, lifetime), and
a specificity of 1.0 for both were reported [19]. In the
same study, Kappa values of 0.82 for single major de-
pression and 0.9 for recurrent major depression were
found for the agreement of 1-month CIDI-based diagno-
sis and clinician-diagnosis. Substantial test-retest reliabil-
ity has been shown for the M-CIDI [15].
Further 12-month mental disorders were assessed by
the DIA-X/M-CIDI: other mood disorders (dysthymia,
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bipolar disorder I and II), anxiety disorders (panic dis-
order, agoraphobia, generalized anxiety disorder, social
phobia, specific phobias, obsessive-compulsive disorder,
post-traumatic stress disorder (PTSD)), somatoform dis-
orders (pain disorder, undifferentiated somatoform dis-
order measured with the Somatic Symptom Index,
SSI4,6; [20]), substance use disorders (alcohol and medi-
cation/drug abuse and dependence) without nicotine
dependence, possible psychotic disorders (screening
without further differential diagnosis), eating disorders
(anorexia nervosa, bulimia nervosa, binge eating dis-
order) and mental disorder due to general medical con-
ditions or substance induced disorders.
Depression severity
In addition to the presence of any comorbid mental dis-
order as described above excluding MDD, the following
depression severity indicators were defined. For partici-
pants with MDD, the number of depression symptoms
affirmed in the CIDI depression section was categorized
into the following groups taking the lower and upper
quartile as cut-offs: 5 symptoms (mild depression), 6–7
symptoms (moderate depression) and 8–9 symptoms
(severe depression). Moreover, affirmation of thoughts
about death or suicidal plan or attempt was established
as a second CIDI-based severity indicator. Psychiatric
comorbidity was determined for all participants based
on all mental disorders assessed excluding MDD. Based
on the self-administered German version of the Patient
Health Questionnaire-9 (PHQ-9) [21, 22], which was
assessed in all participants in DEGS1 and in DEGS1-
MH, two additional severity indicators were defined:
first, having depressive symptoms in both PHQ-9 assess-
ments (i.e. sum score of 10 or more points in DEGS1
and DEGS1-MH) [21, 23] and second, having reported
thoughts of being better off dead or of hurting oneself
for at least several days in both PHQ-9 assessments.
Socio-demographic and health related characteristics
In DEGS1, sex, age, marital status, employment status
and a range of further socio-demographic and health-
related characteristics were assessed. Number of out-
patient physician visits (excluding dentist visits) in the
past 12 months was determined in a self-administered
questionnaire based on a comprehensive list of medical
disciplines. Including medical psychotherapist and
psychological psychotherapist visits, the number of out-
patient visits (minimum 0, maximum 155) was catego-
rized into quartiles (0–2, 3–5, 6–9, ≥10) for analyses.
Education was grouped into low, middle and high based
on the Comparative Analysis of Social Mobility in Indus-
trial Nations (CASMIN) [24]. Socio-economic status
(SES) was classified as low, middle and high using an
index based on information on education, occupational
status and net household income [25]. Self-perceived so-
cial support was assessed using the Oslo-3 Social Sup-
port Scale and categorized as poor (3–8 points),
moderate (9–11 points) and strong support (12–14
points) [26]. Community size was determined based on
official administrative municipal codes for the place of
residence. Health-related quality of life was examined
using the physical and mental component scores of the
Short Form 36 (SF-36) [27, 28].
Statistical analyses
Proportions are reported with 95% confidence intervals
(95%CI). Pearson’s χ2 test was used to determine
whether two categorical variables were independent on a
significance level of 0.05. Associations were determined
using bivariate and multivariate logistic regression
models. To test for trend over the age groups, age group
was included in the logistic regression model as a con-
tinuous variable. To analyse whether time lag between
DEGS1 and DEGS1-MH has an influence on the results,
the following analyses were carried out: Sensitivity ana-
lyses were conducted by excluding the upper quartile
from the analyses (time lag to >25 weeks). Additionally,
cross-tables showing the overlap of CIDI-based MDD
and clinician-diagnosed depression stratified for the time
lag (0–25 weeks vs. more than 25 weeks) can be found
in the Additional file 1. Further, a logistic regression
model with CIDI-based MDD as dependent variable and
clinician-diagnosed depression as independent variable
was calculated, including an interaction term of
clinician-diagnosed depression and time lag (in quar-
tiles). The interaction term was not significant (p =
0.152).
Analyses were conducted with a weighting factor
which 1) accounts for the complex sampling design (se-
lection probability of the sample point and selection
probability of the respondent within the sample point)
and 2) corrects sample deviations from the population
structure as of 31 Dec 2010 with regard to age group,
sex, region, nationality, community type, education and
participation in DEGS1-MH [11, 14, 29]. Confidence in-
tervals were determined using STATA’s survey proce-
dures (STATA 14), which takes into account the
weighting and the correlation of participants within a
sample point. A non-responder analysis and a compari-
son with data from official statistics indicate that the
DEGS1 sample is highly representative of the population
aged 18–79 years in Germany [29].
Results
Of n = 4483 participants of DEGS1-MH, n = 101 (2.3%)
had missing values in at least one of both measures,
resulting in a study sample of n = 4382. In the sample,
50.9% (95%CI 48.9–52.9) were female, 19.2% (95%CI
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17.9–20.5) were 18–29 years old, 24.9% (95%CI 23.3–
26.6) were 30–44 years old, 36.0% (95%CI 34.2–37.8)
were 45–64 years old and 20.0% (95%CI 18.7–21.3) were
65–79 years old. Overall, there were 78.8% (95%CI 76.8–
80.7) married and living with the partner or in a steady
relationship. The distribution of CASMIN educational
level was 35.0% (95%CI 32.5–37.5) for low, 50.8%
(95%CI 48.7–52.9) for middle and 14.2% (95%CI 12.6–
16.0) for high.
Mental disorders among participants with a clinician-
diagnosed depression
Among those reporting a clinician-diagnosed depression,
73.4% had any mental disorder, of which anxiety disor-
ders and affective disorders were the most frequent ones
(Table 1). The proportion of all mental disorders was
higher in participants with a clinician-diagnosed depres-
sion than in participants without a clinician-diagnosed
depression in the past 12 months.
MDD among participants with a clinician-diagnosed
depression
Among participants with a clinician-diagnosed depres-
sion, no substantial differences in the proportion of
MDD and of any other mental disorder were found be-
tween men and women (Fig. 1). The percentage of par-
ticipants with a clinician-diagnosed depression who also
met the criteria of MDD was 62.6% in the age group of
18–29 years (and 3.9% remained without any mental dis-
order) and decreased to 29.8% in the age groups of 65–
79 years (and 39.8% remained without any mental dis-
order). The odds of meeting the criteria of MDD when
reporting a clinician-diagnosed depression decreased per
age group (OR: 0.6, 95%CI 0.4–0.9; ptrend = 0.021). The
vast majority of those without clinician-diagnosed de-
pression did not fulfil the criteria of MDD (men: 97.3%,
95%CI 96.3–98.0; women: 92.7%, 95%CI 90.9–94.2; 18–
29 years: 92.2%, 95%CI: 88.8–94.6; 30–44 years: 93.1%,
95%CI 90.1–95.2; 45–64 years: 96.7%, 95%CI 95.6–97.5;
65–79 years: 97.3, 95%CI 95.5–98.4).
Among participants with a clinician-diagnosed depres-
sion, meeting the criteria of MDD was more likely with
any other mental disorder present and with current de-
pressive symptoms and the suicide item affirmed in both
PHQ-9 assessments (Table 2).
Clinician-diagnosed depression among participants with
MDD
Among participants with MDD, the proportion of a
clinician-diagnosed depression did not differ between
men and women, but it was lower in participants of
younger than of older age (Table 3). Among those with-
out MDD, the vast majority did not report a clinician-
diagnosed depression.
Among participants with MDD, clinician-diagnosed
depression was less often reported by those aged 18–29
years (OR: 0.3, 95%CI 0.1–0.7; p = 0.004) and 30–44
years (OR: 0.3, 95%CI 0.1–0.8; p = 0.014) compared to
the age group of 45–64 years. When adjusting for sex
and the number of outpatient physician visits, these dif-
ferences between the age groups, i.e. the different pro-
portion of clinician-diagnosed depression among those
with MDD, did not remain significant. In those aged
65–79 years with MDD, clinician-diagnosed depression
was reported as often as by those aged 45–64 years (0.8,
95%CI 0.3–1.9; p = 0.641).
Among those with MDD, participants with any comor-
bid mental disorder and with severe MDD were more
likely of reporting clinician-diagnosed depression
(Table 4).
The only depression symptom associated with higher
odds of reporting a clinician-diagnosed depression was
Table 1 Proportion of mental disorders among participants with and without a clinician-diagnosed depression
12-month clinician-diagnosed depression
(n = 249)
No 12-month clinician-diagnosed depression
(n = 4133)
p
12-month mental disorders %(w) (95%CI) %(w) (95%CI)
Any anxiety disordera 54.7 (46.0–63.1) 16.8 (15.2–18.6) <0.0001
Any affective disorderb 51.8 (42.9–60.5) 7.4 (6.4–8.5) <0.0001
Possible psychotic disorder (screening) 17.3 (11.2–25.9) 2.0 (1.5–2.6) <0.0001
Any substance use disorderc 15.2 (10.7–21.2) 5.4 (4.4–6.5) <0.0001
Any somatoform disorderd 14.8 (10.4–20.7) 3.0 (2.4–3.8) <0.0001
Any GMC/substance induced disorder 7.7 (3.4–16.4) 0.8 (0.5–1.2) <0.0001
Any eating disordere 3.5 (1.0–11.5) 0.8 (0.6–1.3) 0.0227
Any of the above 73.4 (64.2–80.9) 26.0 (24.1–28.0) <0.0001
a including panic disorder, agoraphobia, generalized anxiety disorder, social phobia, specific phobias, obsessive-compulsive disorder, PTSD
b including major depression, dysthymia, bipolar disorder I or II
c including alcohol and medication abuse and dependence
d pain disorder and undifferentiated somatoform disorder as measured by the Somatic Symptom Index, SSI4,6 (Escobar et al., 1989)
e including anorexia nervosa, bulimia nervosa, binge eating disorder
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“thoughts of death or suicide, or having suicide plan or
attempt” (results for other symptoms not shown).
Socio-demographic, health-related and mental health
characteristics of participants with a clinician-diagnosed
depression and MDD, with a clinician-diagnosed depression
only and MDD only
Further analyses found significant overall differences of
each socio-demographic characteristic considered be-
tween participants with clinician-diagnosed depression
and MDD, with clinician-diagnosed depression only,
with MDD only, and the non-cases according to both in-
struments (see Additional file 2). Participants with
clinician-diagnosed depression who also met the criteria
of MDD had the least favourable socio-demographic dis-
tributions, e.g. highest percentage of unmarried and
without steady relationship, low SES, poor social
support, never employed. Participants with clinician-
diagnosed depression with and without MDD had higher
numbers of outpatient physician visits and of chronic
somatic conditions and a lower physical health related
quality of life than participants with MDD only. Mental
health related quality of life was lowest among partici-
pants with clinician-diagnosed depression and MDD.
The proportion of mental disorders was the highest in
participants with clinician-diagnosed depression who also
met the criteria of MDD than in participants with a
clinician-diagnosed depression only or MDD only, though
not significantly throughout the disorders examined (see
Additional file 3). Compared to participants with a
clinician-diagnosed depression only and MDD only, those
identified by both measures had a higher proportion of
PHQ-9 current depressive symptoms and of PHQ-9 sui-
cidal item affirmed in DEGS1 and DEGS1-MH.
29.8 (17.9-45.2)
33.0 (23.1-44.7)
43.8 (21.5-69.0)
62.6 (37.8-82.1)
36.0 (26.0-47.4)
39.9 (28.1-53.1)
37.2 (28.8-46.5)
30.4 (17.9-46.7)
38.6 (28.4-50.0)
37.8 (19.0-61.3)
33.5 (15.0-59.0)
37.4 (27.1-48.9)
33.5 (22.4-46.7)
36.2 (28.0-45.2)
39.8 (24.2-57.8)
28.3 (17.8-41.9)
18.4 (7.0-40.2)
3.9 (0.5-24.0)
26.6 (17.3-38.6)
26.6 (16.5-39.8)
26.6 (19.1-35.8)
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65-79 years (N=61)
45-64 years (N=137)
30-44 years (N=28)
18-29 years (N=23)
Women (N=168)
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Fig. 1 Cumulative proportions of 12-month major depressive disorder (MDD) and any other mental disorder1 among participants with clinician-
diagnosed depression in the past 12 months. 1Including dysthymia, bipolar disorder I and II, panic disorder, agoraphobia, generalized anxiety
disorder, social phobia, specific phobias, obsessive-compulsive disorder, PTSD, pain disorder, undifferentiated somatoform disorder, alcohol and
medication abuse and dependence, possible psychotic disorders (screening without further differential diagnosis), anorexia nervosa, bulimia
nervosa, binge eating disorder, mental disorder due to general medical conditions or substance induced disorders.
Table 2 Proportion of major depressive disorder (MDD) among participants with clinician-diagnosed depression across depression
severity indicators
Participants with a clinician-diagnosed depression in the past 12 months (n = 249)
12-month MDD No 12-month MDD
Row
%(w) (95%CI)
Row
%(w) (95%CI)
Bivariate OR
(95%CI)
p Adjusted ORa
(95% CI)
p
Any comorbid mental disorderb (N = 171) 48.0 (37.0–59.2) 52.0 (40.8–63.0) 6.4 (2.4–17.2) <0.001 5.8 (2.2–15.3) <0.001
No comorbid mental disorder (N = 78) 12.6 (5.9–25.0) 87.4 (75.0–94.1) Ref. Ref.
Current depressive symptomsc(N = 64) 63.4 (46.9–77.3) 36.6 (22.7–53.1) 4.6 (2.3–9.5) <0.001 4.6 (2.2–9.5) <0.001
No current depressive symptoms (N = 185) 27.2 (19.5–36.6) 72.8 (63.4–80.5) Ref. Ref.
Affirmed suicide itemd (N = 52) 63.9 (45.5–79.0) 36.1 (21.0–54.5) 4.2 (1.7–10.0) 0.002 4.1 (1.7–10.1) 0.002
Suicide item not affirmed (N = 197) 29.8 (21.4–40.0) 70.2 (60.0–78.6) Ref. Ref.
a adjusted for sex and age
b dysthymia, bipolar disorder I and II, panic disorder, agoraphobia, generalized anxiety disorder, social phobia, specific phobias, obsessive-compulsive disorder,
PTSD, pain disorder, undifferentiated somatoform disorder, alcohol and medication abuse and dependence, possible psychotic disorders (screening without further
differential diagnosis), anorexia nervosa, bulimia nervosa, binge eating disorder, mental disorder due to general medical conditions or substance induced disorders
c PHQ-9 current depressive symptoms (sum score ≥10) in DEGS1 and DEGS1-MH
d PHQ-9 suicide item affirmed (at least several days) in DEGS1 and DEGS1-MH
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Discussion
Based on a nationally representative sample of the gen-
eral adult population, this study shows that a large pro-
portion of survey participants who report a previously
clinician-diagnosed depression meets criteria of at least
one DSM-IV mental disorder. At the same time, there
were major differences between participants reporting a
clinician-diagnosed depression and participants who
meet criteria for major depression in a comprehensive
standardized diagnostic interview.
The findings of this study should be considered in the
context of several limitations. First, the time lag between
DEGS1 and DEGS1-MH might have led to an
underestimation of the overlap of both measures exam-
ined and of the prevalence of mental disorders among
participants with a clinician-diagnosed depression due to
remission or to the time difference between both assess-
ments. Analyses limiting the time lag to ≤25 weeks led
to a slight increase of overlap, but the results did not
substantially change. The time-lag stratified analyses of
the overlap of both measures indicates that the time lag
might have led to an age- or sex-specific under- or over-
estimation of the overlap. However, the confidence inter-
vals are large due to the small numbers of cases in the
upper quartile. Second, the measure of a clinician-
diagnosed depression is diffuse in two ways. The word-
ing of the question leaves it unclear whether the depres-
sion diagnosis was made in the past 12 months or
whether the respondent had received a diagnosis previ-
ously and interprets depressive symptoms in the past
12 months as a continuation. Further, the measure de-
pends on the respondent’s ability to recall a depression
diagnosis, which however also applies for symptom re-
ports in the CIDI. Third, the mental disorders assessed
in DEGS1-MH does not include all possible disorders,
hence the prevalence of any other mental disorder might
be underestimated. Fourth, the small number of cases
results in large confidence intervals and restricts ana-
lyses with respect to the number of strata.
Despite these limitations, this study contributes to a
better understanding of survey results based on the
measure of a clinician-diagnosed depression. There are
four noteworthy findings. First, there was a remarkable
age pattern: Among participants with a clinician-
diagnosed depression, the proportion of those meeting
Table 3 Proportion of participants with and without clinician-
diagnosed depression among participants with and without
major depressive disorder (MDD)
12-month clinician-diagnosed
depression in participants
with 12-month MDD
No 12-month clinician-
diagnosed depression
in participants without
12-month MDD
%(w) (95%CI) %(w) (95%CI)
Total 33.0 (25.9–40.9) 95.8 (94.8–96.6)
Sex
Men 37.1 (26.0–49.7) 97.6 (96.6–98.3)
Women 31.3 (22.9–41.1) 94.0 (92.1–95.5)
Age group (years)
18–29 years 22.7 (12.4–37.9) 98.5 (96.8–99.3)
30–44 years 20.3 (8.8–40.3) 97.6 (96.1–98.6)
45–64 years 49.3 (38.3–60.4) 93.6 (91.4–95.4)
65–79 years 44.2 (26.5–63.5) 95.0 (92.7–96.6)
Table 4 Proportion of clinician-diagnosed depression among participants with major depressive disorder (MDD) across depression
severity indicators
Participants who met the criteria for 12-month MDD (n = 284)
12-month clinician-
diagnosed depression
No 12-month clinician-
diagnosed depression
Row
%(w) (95%CI)
Row
%(w) (95%CI)
Bivariate OR (95%CI) p Adjusted ORa (95% CI) p
Any comorbid mental disorderb 37.9 (29.4–47.3) 62.1 (52.7–70.6) 3.3 (1.3–8.5) 0.012 6.6 (1.7–25.6) 0.006
No comorbid mental disorderb 15.5 (7.4–29.8) 84.5 (70.2–92.6) Ref. Ref.
Number of depression symptoms
Mild (5/9 symptoms) 19.0 (10.5–31.9) 81.0 (68.1–89.5) Ref. Ref.
Moderate (6&7/9 symptoms) 27.2 (19.4–36.7 72.8 (63.3–80.6) 1.6 (0.7–3.7) 0.275 2.3 (0.9–5.4) 0.066
Severe (8&9/9 symptoms) 49.5 (34.4–64.7) 50.5 (35.3–65.6) 4.2 (1.7–10.4) 0.002 7.0 (2.6–19.0) <0.001
Thoughts of death or suicide, or
having suicide plan or attemptc
41.8 (32.3–52.0) 58.2 (48.0–67.7) 3.6 (1.8–7.3) <0.001 3.2 (1.4–7.4) 0.006
No thoughts of death or suicide,
or having suicide plan or attemptc
16.5 (10.2–25.6) 83.5 (74.4–89.8) Ref. Ref.
a adjusted for sex, age groups, number of outpatient physician visits
b dysthymia, bipolar disorder I and II, panic disorder, agoraphobia, generalized anxiety disorder, social phobia, specific phobias, obsessive-compulsive disorder,
PTSD, pain disorder, undifferentiated somatoform disorder, alcohol and medication abuse and dependence, possible psychotic disorders (screening without further
differential diagnosis), anorexia nervosa, bulimia nervosa, binge eating disorder, mental disorder due to general medical conditions or substance induced disorders
c based on the CIDI depression section
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the criteria of MDD was 62.6% in those aged 18–29
years and decreased per age group to 29.8% in those
aged 65–79 years. A similar yet less pronounced age pat-
tern was found in a large community-based study in the
US [5]. Interestingly, our results show that 96.1% of
young adults who report a clinician-diagnosed depres-
sion had any mental disorder, while 39,8% of adults aged
65–79 years did not have any disorder even though
reporting a health professional-diagnosed depression.
The relatively high proportion of 62.6% MDD among
those aged 18–29 years is higher than the 42.0% that
was reported in a meta-analysis on the accuracy of un-
assisted depression diagnosis in primary care [30] and
equal to the proportion of 66.5% which was reported for
the optimal threshold for the CIDI screening scale [31].
Our study indicates that a clinician-diagnosed depres-
sion reported by this age group in a health survey might
include to a large part participants who actually fulfilled
the MDD criteria. A possible explanation for this finding
is the higher prevalence of severe depression among de-
pressed young adults [10] which might lead to more ac-
curate diagnoses by health professionals. Also, health
professionals might be more rigorous in diagnosing de-
pression when it comes to younger patients because of
its possible psychological impact on the life young
people. Further, the high prevalence of depression in
young adults [9, 10, 14, 32] might result in a higher
number of “true positives” than in populations with
lower depression prevalence. The high proportion of
middle-aged and older participants with a clinician-
diagnosed depression who did not meet the criteria of
MDD implies a substantial amount of over-diagnosis of
depression for these groups, replicating results from pri-
mary care in Italy [6] and the US [5]. Increased physical
complaints in older age could be misinterpreted as
symptoms of depression by health professionals [33, 34].
Additionally, underreporting of depressive symptoms by
older participants in the CIDI due to its complex ques-
tioning and its multiple time frames [35] and due to
problems recalling the symptoms are possible methodo-
logical explanations. Research has suggested that older
adults more frequently show clinically significant depres-
sive symptoms without fulfilling all diagnostic criteria
[36]. In this context, our finding could at least partly be
explained by the fact that the depression diagnosis based
on the CIDI might exclude older people due to the diag-
nostic algorithm who might have reported significant
symptoms to the health professional, resulting in a de-
pression diagnosis.
The second notable result is the striking age pattern
of the proportion of clinician-diagnosed depression
among participants with MDD (low in young age groups
and highest in those aged 45–64 years). Obviously, these
findings cannot be interpreted as the percentage of
actual unrecognition of depression by health profes-
sionals. Instead, it reflects the specific preconditions of
the measure of a clinician-diagnosed depression reported
by the respondent. Thus, our findings supposedly mirror
to a large part the lack of any health professional contact
in people with mood disorders [37] and the fact that
young adults are less likely to use professional health
services due to mental health problems [38–40] than
older adults, but prefer seeking help rather from family
or friends [41]. Additionally, low numbers of physician
contacts are reported for younger adults [42], reducing
the odds for a physician to detect depression [8, 43].
This is supported by the fact that the age pattern disap-
peared after controlling for the number of outpatient
physician visits. In contrast to the US, where financial
barriers have been reported the most common reasons
for not seeking professional help for mental health prob-
lems [44], personal help-seeking barriers such as self-
and perceived stigmatization [45–47] are likely more
relevant in Germany, as diagnosis and treatment of men-
tal disorders are covered by mandatory health insurance.
As to depression recognition itself, our results reflect the
considerable amount of unrecognized depression in pri-
mary care in Germany and internationally [8, 30, 48],
which was suggested of being the most pronounced in
younger people [7]. In addition, health professionals
might not always fix and communicate a depression
diagnosis to the patient [49]. Not least, self-
stigmatization might lead to a reporting bias of a depres-
sion diagnosis in the survey interview.
Third, it is remarkable that no differences were found
between men and women. On one hand, concerning the
similar level of the proportion of MDD among men and
women with a clinician-diagnosed depression, our re-
sults agree with findings from the US [5]. On the other
hand, the fact that we did not find any sex difference re-
garding the proportion of clinician-diagnosed depression
among those with MDD is contra-intuitive as research
has suggested sex-specific barriers to help seeking [50],
utilization of somatic and mental health services [42,
51], symptom reporting [52] and depression recognition
rates [8].
Fourth, we found that participants with severe de-
pression according to different severity indicators were
more likely to be classified as cases by both measures.
This is plausible considering that research found an as-
sociation of seriousness of mental disorder with service
use [38] and higher proportions of depression recogni-
tion in primary care when depression was severe and
when suicidal ideation or tendency was reported by the
patient [8]. This finding indicates that a considerable
part of participants with severe depression is included
in the measure of a clinician-diagnosed depression. In
addition to the explanations given above, this finding
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can also be interpreted in the context of discussions
about the DSM-IV potentially assigning a depression
diagnosis partly to people without relevant disability
[53]. Following this discourse, participants with depres-
sion without relevant disabilities might have qualified
for a depression diagnosis in the CIDI, but were un-
likely to seek for professional help due to their lack of
disability.
Conclusions
This study contributes to a better understanding of sur-
vey results based on the respondent’s report of a
clinician-diagnosed depression. It shows that a large pro-
portion of survey participants who report a clinician-
diagnosed depression meets criteria of at least one
DSM-IV mental disorder (most frequently any affective
and any anxiety disorder) according to the CIDI. How-
ever, substantial differences exist between participants
who report a clinician-diagnosed depression and partici-
pants who meet criteria for depression in a comprehen-
sive standardized diagnostic interview. Furthermore,
concordance of both measures varies with age and sever-
ity of depressive symptoms. Thus, respondent reports of
clinician-diagnosed depression cannot be considered a
short alternative for CIDI-based major depression in
studies of the general population. This needs to be con-
sidered when interpreting survey results based on re-
ports about clinician-diagnosed depression.
Instead, this study underlines the importance to assess
a range of depression indicators in health surveys in
order to cover a wide spectrum. For many research
questions, information about depression diagnosis in the
health care system is important. But if information on
depressive symptoms or on the presence of diagnostic
criteria is needed, further indicators such as standardized
diagnostic interviews or one of the established short
screening scales, which have been shown to have good
concordance with diagnoses based on independent re-
search diagnostic interviews [21, 31], should be addition-
ally assessed.
Regarding clinical practice, our findings first imply that
if patients report that they have not been diagnosed with
depression, they most likely do neither have a history of
major depression. Second, relating to younger patients,
health professionals should be especially attentive and
keep a possible major depression in mind when depressive
symptoms are reported in order to provide adequate treat-
ment. Third, relating to older patients, our results imply
that health professionals should on one hand be more
rigorous when diagnosing depression in order to reduce
over-diagnosis and over-treatment as a consequence. On
the other hand, however, health professionals should con-
sider determining a differential depression diagnosis when
depressive symptoms are reported by elderly in order to
increase recognition and adequate depression treatment
in this age group.
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